Maintained activity in ankylosing spondylitis patients treated with TNFi and/or NSAID for at least 12 weeks: a cross-sectional study in Brazil
Abstract Background The aim of this study was to evaluate disease activity among patients with axial spondyloarthritis (AS) treated with tumor necrosis factor inhibitors (TNFi) and/or nonsteroidal anti-inflammatory drugs (NSAIDs) for at least 12 weeks in private outpatient settings in Brazil. Method...
Main Authors: | Ricardo Acayaba de Toledo, Felipe Merchan Ferraz Grizzo, Vander Fernandes, Renato Calheiros, Ricardo T. Russo, Gustavo Rosal, Luiz Roberto Delboni Marchese, Roberto Tunala, Renato Watanabe, Marina Gabriela Birck, Guilherme Silva Julian, Francisco Jose Forestiero |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-10-01
|
Series: | Advances in Rheumatology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s42358-022-00270-3 |
Similar Items
-
Ankylosing Spondylitis
by: Nazanin Ebrahimiadib, et al.
Published: (2021-07-01) -
CLINICAL EXPERIENCE WITH ETANERCEPT IN THE TREATMENT OF PATIENTS WITH ANKYLOSING SPONDYLITIS
by: O. A. Rumyantseva, et al.
Published: (2018-05-01) -
THE NEED AND POSSIBILITIES OF EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS: COMMENTARIES ON THE PAPER «EARLY DIAGNOSIS OF ANKYLOSING SPONDYLITIS» (No. 4, 2013) AND DISCUSSION IN THE JOURNAL (No. 2, 2014)
by: Sh. F. Erdes
Published: (2014-09-01) -
Probiotics in Ankylosing Spondylitis: A Possible Potency
by: Sumartini Dewi, et al.
Published: (2020-07-01) -
USE OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS FOR THE TREATMENT OF AXIAL SPONDYLOARTHRITIS, INCLUDING ANKYLOSING SPONDYLITIS, MONITORING THEIR EFFICACY AND SAFETY (DRAFT GUIDELINES OF THE EXPERT SPONDYLOARTHRITIS DIAGNOSIS AND TREATMENT GROUP)
by: I. Z. Gaidukova, et al.
Published: (2016-09-01)